BVS (BVS) Stock Price & Analysis
BVS (BVS) fell 2.02% to USD 14.07 as of September 8, 2026 at 09:04 UTC, according to Nexqual real-time market data.
BVS last closed at USD 14.07; the session ranged USD 13.91–14.31 on volume of 502,334 shares. Market capitalization is —, with a 52-week range of USD 6.26–15.89 (NMS). Source: Nexqual, September 8, 2026 at 09:04 UTC.
Key Statistics (as of September 8, 2026 at 09:04 UTC)
| Price | USD 14.07 |
|---|---|
| Change | ▼ 2.02% (down) |
| Previous Close | USD 14.07 |
| Open | USD 14.07 |
| Day Range | USD 13.91 – 14.31 |
| 52-Week Range | USD 6.26 – 15.89 |
| Volume | 502,334 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (BVS)
Nexqual's technical model rates BVS "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 09:04 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 57.19 (neutral) |
| vs SMA50 | Above (USD 12.88) |
| MACD | 0.32 (positive) |
From BVS's Latest SEC 10-K Filing (filed 2026-03-05)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AVAH | Aveanna Healthcare Holdings Inc | USD 13.58 | ▲ 2.88% |
| TMCI | Treace Medical Concepts, Inc. | USD 4.81 | ▲ 2.34% |
| ANNX | Annexon, Inc. | USD 4.87 | ▼ 1.22% |
| DSGN | Design Therapeutics, Inc. | USD 15.14 | ▼ 2.51% |
| AFIB | Acutus Medical Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:04 UTC. This page is informational and not investment advice.